AIM ImmunoTech LOGO.jpg
AIM ImmunoTech to Present at the Q1 Virtual Investor Summit on March 24th
11 mars 2021 07h00 HE | AIM ImmunoTech Inc.
OCALA, Fla., March 11, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – AIM ImmunoTech Inc. (NYSE American: AIM) today announced that Thomas K. Equels, Chief Executive Officer of AIM ImmunoTech, will be...
ScipherTM.png
WellDyne Partners with Scipher Medicine to Improve Patient Outcomes and Lower Costs for Rheumatoid Arthritis Care
11 févr. 2021 08h00 HE | Scipher Medicine Corporation
WALTHAM, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Scipher Medicine, a precision immunology company matching patients with their most effective therapy, today announced a partnership with WellDyne, a...
ScipherTM.png
Scipher Medicine Brings Precision Medicine Platform to Patient-Centered MIT Initiative
03 févr. 2021 08h00 HE | Scipher Medicine Corporation
WALTHAM, Mass., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Scipher Medicine, a precision immunology company matching patients with the most effective therapy, announced today they have partnered with...
anpac_logo_full color_stacked.png
AnPac Bio Granted a New US patent on Novel Medical Device for Multi-Cancer Detection
01 févr. 2021 07h30 HE | Anpac Bio, USA
SAN JOSE, Calif., Feb. 01, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
Logo (3).png
Plasma Fractionation Market to Reach $41.4 Billion by 2027, Growing at a CAGR of 7% From 2020 With COVID-19 Impact - Meticulous Research® Analysis
14 janv. 2021 08h16 HE | Meticulous Market Research Pvt. Ltd.
London, Jan. 14, 2021 (GLOBE NEWSWIRE) -- In its latest publication, titled “Plasma Fractionation Market by Product [Immunoglobulins (Intravenous, Subcutaneous), Coagulation Factors, Albumin],...
22157.jpg
Global Crohn's Disease Forecast and Market Analysis Report 2020-2027 - Despite Formulary Constraints, Novel Pipeline Drugs will Expand the Market
12 janv. 2021 07h03 HE | Research and Markets
Dublin, Jan. 12, 2021 (GLOBE NEWSWIRE) -- The "Crohn's Disease Forecast and Market Analysis to 2027" report has been added to ResearchAndMarkets.com's offering. As specialty products, therapies...
Reports and Data.jpeg-01
Single-Cell Analysis Market Size Worth USD 6.98 Bn By 2027 | CAGR:17.2% | Reports and Data
14 déc. 2020 09h22 HE | Reports and Data
New York, Dec. 14, 2020 (GLOBE NEWSWIRE) -- The increasing emphasis on personalized medicine and the government's growing investment in cell-based research are driving the demand for the market. ...
anpac_logo_full color_stacked.png
AnPac Bio Makes Significant Progress in Detecting Pre-cancer Diseases and Recorded Over 20 Types of Pre-cancer Diseases
14 déc. 2020 07h30 HE | Anpac Bio, USA
SAN JOSE, Calif., Dec. 14, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in China and the United...
Pappas_LinkedIn_Image
New Study Demonstrates Clinical Utility of PrismRA® Test in Guiding Therapy Selection for Rheumatoid Arthritis Patients
07 déc. 2020 08h06 HE | Scipher Medicine Corporation
WALTHAM, Mass., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Scipher Medicine, a precision immunology company matching patients with the most effective therapy, today announced findings from a clinical utility...
anpac_logo_full color_stacked.png
Anpac Bio Announces Change of Auditor
04 déc. 2020 16h01 HE | Anpac Bio, USA
SAN JOSE, Dec. 04, 2020 (GLOBE NEWSWIRE) -- Anpac Bio-Medical Science Co., Ltd. (“Anpac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in China and the United States...